PD-1+ CD4 T cells are associated with HIV reservoir size and impaired function of T follicular helper cells in children and young adults on long-term viral control

Standardising neonatal and pediatric anitibiotic clinical trial design and conduct: the PENTA-ID network review

Season’s Greetings from Penta!

Data from ODYSSEY are used by ViiV Healthcare to file FDA and EMA submissions for the first-ever dispersible formulation of dolutegravir for children living with HIV

Role of Magnetic Resonance Imaging and cranial ultrasonography in congenital Cytomegalovirus infection

Human Rights Day

Picturing Health launches new video on adolescents with HIV

World AIDS Day 2019: Communities make the difference

Modulated Zika virus NS1 conjugate offers advantages for accurate detection of Zika virus specific antibody in double antigen binding and Ig capture enzyme immunoassays

Universal Children’s Day

European Antibiotic Awareness Day

Penta’s Davide Bilardi wins award for outstanding research work

Analysing small groups within clinical trials, while borrowing information from larger groups

Yellow Fever virus reemergence and spread in southeast Brazil, 2016-2019

Factors predicting the severity of dengue in patients with warning signs in Rio de Janeiro, Brazil (1986–2012)

EPIICAL data on Journal of AIDS: treat early, suppress fast!

Reduced time to suppression among neonates with HIV initiating antiretroviral therapy within 7 days of age

Time to HIV suppression in perinatally infected infants depends on the viral load and CD4 T-cell percentage at the start of treatment